![Liver graphic Liver graphic](/sites/default/files/2024-06/EASL%20SEO%20Teaser%20Card%20Image_1440%20x%20810px.jpg)
June 07, 2024
Results from Phase II MASH trial presented at EASL 2024
![Boehringer inhalers now available at $35 a month for eligible patients Woman with brown hair standing outside in front of blue sky](/sites/default/files/2024-05/Boehringer_Lifestyle_SocialLife_MeetingFriends_1400.jpg)
June 01, 2024
Boehringer inhalers now available at $35 a month for eligible patients
![Pharmacist talking with patient Pharmacist talking with patient](/sites/default/files/2024-05/Quallent-Announcement.jpg)
May 13, 2024
New agreement with Quallent expands biosimilar access
![Improving Access to Clinical Trials Scientists](/sites/default/files/2024-05/Boehringer_Workplace_Lab_Discussion-01_RGB_004.jpg)
May 02, 2024
Improving Access to Clinical Trials
![FDA Approves Additional Formulation of Our Biosimilar Doctor speaking with patient.](/sites/default/files/2024-04/Press%20release%20image_0.jpg)
May 01, 2024
FDA Approves Additional Formulation of Our Biosimilar
![Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline.](/sites/default/files/2024-04/boehringer_biopharmaceutical%20production_Biberach%20resized_0.jpg)
April 16, 2024
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline.
![Results announced from EMPACT-MI phase III trial Scientists working together](/sites/default/files/2024-04/Scientists_working_together.jpg)
April 06, 2024
Results announced from EMPACT-MI phase III trial
![researcher working in a lab photo of male researcher working in a lab](/sites/default/files/2024-03/Boehringer_Workplace_Lab_Research.jpg)
March 19, 2024
New FDA approval for the treatment of GPP
March 12, 2024
Update on sNDA for fibrosing ILD in children and adolescents
![Boehringer Ingelheim caps patient out-of-pocket costs for its inhaler portfolio at $35 per month Boehringer Ingelheim caps patient out-of-pocket costs for its inhaler portfolio at $35 per month](/sites/default/files/2024-03/Boehringer_Lifestyle_PhysicalActivity_ExercisingOutdoors.jpg)
March 07, 2024
Boehringer Ingelheim caps patient out-of-pocket costs for its inhaler portfolio at $35 per month
![Top-line Phase II Data for treatment of MASH Liver Illustration](/sites/default/files/2024-03/Survodutide-MASH-Phase-II-Top-Line.jpg)
February 26, 2024
Top-line Phase II Data for treatment of MASH
![photo of female physician in conversation with colleagues](/sites/default/files/us/2023-11/physician-conversation.png)
November 20, 2023
National Psoriasis Foundation Releases Consensus Statement on Management of Generalized Pustular Psoriasis (GPP)
![photo of researcher](/sites/default/files/us/2023-11/researcher.jpg)
November 10, 2023
Investigational Compound Granted FDA Orphan Drug Designation
![Kidney Illustration](/sites/default/files/us/2023-11/ASi-EMPA-Kidney.png)
November 06, 2023
Promising Phase II Results in Chronic Kidney Disease
![Kidney Illustration](/sites/default/files/us/2023-11/Klinrisk-ASN.jpg)
November 04, 2023
AI-Driven Model Validated to Predict Risk of CKD Progression
![doctor, patient and Rob Base doctor, patient and Rob Base](/sites/default/files/us/2023-11/It-Takes-2-Still_0.jpg)
November 01, 2023
Hip-Hop Classic “It Takes Two” Takes on New Meaning in Remix to Elevate Importance of Testing for Kidney Disease
![two childrens two childrens](/sites/default/files/us/2023-10/Teaser_Press_Release.jpg)
October 30, 2023
Life forward - Boehringer Ingelheim unveils its evolved company brand
![Recipients of the 2023 Prix Galien USA](/sites/default/files/us/2023-11/Prix-Galien-2023.jpg)
October 27, 2023
Boehringer Ingelheim wins 2023 Prix Galien USA
![Physician talking with patient](/sites/default/files/us/2023-09/Cyltezo%20Low%20WAC%20Announcement.jpg)
October 02, 2023
Low-WAC interchangeable biosimilar is now available
![Patient talking to doctor](/sites/default/files/us/2023-09/CKD%20FDA%20Approval_0.jpg)
September 22, 2023
FDA Approved Treatment Option for Adults with CKD
August 28, 2023
Statement by Boehringer Ingelheim on selection of Jardiance® (empagliflozin) by the Centers for Medicare and Medicaid Services (CMS) Drug Price Negotiation Program
![For download: © 2020, Peter Ginter](/sites/default/files/us/2023-08/HY%202023%20press%20release%20image%20resized_0.jpg)
August 02, 2023
First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
![animation of child sitting on couch and smiling with caregiver](/sites/default/files/us/2023-07/snda.jpg)
July 25, 2023
FDA accepts OFEV sNDA for 6–17-year-olds with fibrosing ILD
![Physician talking with patient Physician talking with patient](/sites/default/files/us/2023-07/Cyltezo-ESI-Formulary.jpg)
July 13, 2023